Machine Learning Guided Design of High-Affinity ACE2 Decoys for SARS-CoV-2 Neutralization.
Matthew C ChanKui K ChanErik ProckoDiwakar ShuklaPublished in: The journal of physical chemistry. B (2023)
A potential therapeutic strategy for neutralizing SARS-CoV-2 infection is engineering high-affinity soluble ACE2 decoy proteins to compete for binding to the viral spike (S) protein. Previously, a deep mutational scan of ACE2 was performed and has led to the identification of a triple mutant variant, named sACE2 2 .v.2.4, that exhibits subnanomolar affinity to the receptor-binding domain (RBD) of S. Using a recently developed transfer learning algorithm, TLmutation, we sought to identify other ACE2 variants that may exhibit similar binding affinity with decreased mutational load. Upon training a TLmutation model on the effects of single mutations, we identified multiple ACE2 double mutants that bind SARS-CoV-2 S with tighter affinity as compared to the wild type, most notably L79V;N90D that binds RBD similarly to ACE2 2 .v.2.4. The experimental validation of the double mutants successfully demonstrates the use of machine learning approaches for engineering protein-protein interactions and identifying high-affinity ACE2 peptides for targeting SARS-CoV-2.
Keyphrases
- sars cov
- angiotensin converting enzyme
- machine learning
- angiotensin ii
- wild type
- respiratory syndrome coronavirus
- computed tomography
- binding protein
- artificial intelligence
- magnetic resonance imaging
- deep learning
- coronavirus disease
- magnetic resonance
- mass spectrometry
- capillary electrophoresis
- big data
- copy number
- drug delivery
- dengue virus